Literature DB >> 23925956

Better functional and similar pain outcomes in osteoarthritis compared to rheumatoid arthritis after primary total knee arthroplasty: a cohort study.

Jasvinder A Singh1, David G Lewallen.   

Abstract

OBJECTIVE: To determine the association of the underlying diagnosis with limitation in activities of daily living (ADL) and pain in patients undergoing primary total knee arthroplasty (TKA).
METHODS: Prospectively collected data from the Mayo Clinic Total Joint Registry were used to assess the association of diagnosis with moderate-severe limitation in ADL and moderate-severe pain at 2 and 5 years after primary TKA, using multivariable-adjusted logistic regression analyses. We calculated odds ratios (ORs) and 95% confidence intervals (95% CIs).
RESULTS: There were 7,139 primary TKAs at 2 years and 4,234 at 5 years. In multivariable-adjusted analyses, compared with rheumatoid arthritis (RA)/inflammatory arthritis, osteoarthritis (OA) was associated with significantly lower moderate-severe ADL limitation at 2 years (OR 0.5 [95% CI 0.3-0.8]) (P = 0.004) and at 5 years (OR 0.5 [95% CI 0.3-0.9]) (P = 0.02). There was no significant association of diagnosis of OA with moderate-severe pain at 2 years (OR 1.2 [95% CI 0.5-2.7]) (P = 0.68) or at 5 years (OR 1.0 [95% CI 0.3-3.7]) (P = 1.0).
CONCLUSION: We found that patients with OA who underwent primary TKA had better ADL outcomes compared to patients with RA/inflammatory arthritis at 2 and 5 years. On the other hand, the pain outcomes after primary TKA did not differ in OA versus RA. This suggests a discordant effect of underlying diagnosis on pain and function outcomes after TKA. These novel findings can be used to better inform both patients and surgeons about expected pain and function outcomes after primary TKA. Published 2013. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Year:  2013        PMID: 23925956     DOI: 10.1002/acr.22090

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  7 in total

1.  Rheumatoid Arthritis Flares After Total Hip and Total Knee Arthroplasty: Outcomes at One Year.

Authors:  Susan M Goodman; Serene Z Mirza; Edward F DiCarlo; Diyu Pearce-Fisher; Meng Zhang; Bella Mehta; Laura T Donlin; Vivian P Bykerk; Mark P Figgie; Dana E Orange
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-05-14       Impact factor: 4.794

2.  Patients with Rheumatoid Arthritis have Similar Excellent Outcomes after Total Knee Replacement Compared with Patients with Osteoarthritis.

Authors:  Susan M Goodman; Beverly Johnson; Meng Zhang; Wei-Ti Huang; Rebecca Zhu; Mark Figgie; Michael Alexiades; Lisa A Mandl
Journal:  J Rheumatol       Date:  2015-12-01       Impact factor: 4.666

3.  [Recovery of knee function after total knee arthroplasty: different outcomes in patients with osteoarthritis and rheumatoid arthritis].

Authors:  L Reiss; J Stolle; H-D Carl; B Swoboda
Journal:  Z Rheumatol       Date:  2014-08       Impact factor: 1.372

4.  Polymyositis has minimal effect on primary total knee or hip arthroplasty outcomes.

Authors:  Jasvinder A Singh; John D Cleveland
Journal:  Clin Rheumatol       Date:  2020-01-02       Impact factor: 2.980

5.  Patient Endorsement of the Outcome Measures in Rheumatology (OMERACT) Total Joint Replacement (TJR) clinical trial draft core domain set.

Authors:  Jasvinder A Singh; Michelle Dowsey; Peter F Choong
Journal:  BMC Musculoskelet Disord       Date:  2017-03-15       Impact factor: 2.362

6.  Association of Early Postoperative Pain Trajectories With Longer-term Pain Outcome After Primary Total Knee Arthroplasty.

Authors:  Jasvinder A Singh; Celeste A Lemay; Lisa Nobel; Wenyun Yang; Norman Weissman; Kenneth G Saag; Jeroan Allison; Patricia D Franklin
Journal:  JAMA Netw Open       Date:  2019-11-01

7.  Better clinical outcome of total knee arthroplasty for rheumatoid arthritis with perioperative glucocorticoids and disease-modifying anti-rheumatic drugs after an average of 11.4-year follow-up.

Authors:  Yi Ren; Qi Yang; Xisheng Weng; Bin Feng; Tim Luo; Jin Lin; Jin Jin; Wenwei Qian
Journal:  J Orthop Surg Res       Date:  2021-01-27       Impact factor: 2.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.